|
1
|
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
|
Mol Endocrinol
|
2007
|
1.10
|
|
2
|
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.
|
Am J Physiol Heart Circ Physiol
|
2013
|
1.09
|
|
3
|
Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.
|
J Med Chem
|
2006
|
1.01
|
|
4
|
Ganglionic tyrosine hydroxylase and norepinephrine transporter are decreased by increased sodium chloride in vivo and in vitro.
|
Auton Neurosci
|
2003
|
0.87
|
|
5
|
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists.
|
Bioorg Med Chem Lett
|
2009
|
0.81
|
|
6
|
Effects of angiotensins II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat.
|
Pharmacology
|
2002
|
0.81
|
|
7
|
Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
|
Bioorg Med Chem Lett
|
2009
|
0.79
|
|
8
|
Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
|
Steroids
|
2009
|
0.79
|
|
9
|
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.
|
Bioorg Med Chem Lett
|
2009
|
0.78
|
|
10
|
2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
|
Bioorg Med Chem Lett
|
2009
|
0.78
|
|
11
|
Improving the developability profile of pyrrolidine progesterone receptor partial agonists.
|
Bioorg Med Chem Lett
|
2009
|
0.77
|
|
12
|
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.
|
J Pharmacol Exp Ther
|
2002
|
0.76
|